{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:45:30Z","timestamp":1792003530743,"version":"4.4.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K02436"],"award-info":[{"award-number":["24K02436"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["26K10876"],"award-info":[{"award-number":["26K10876"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25K11250"],"award-info":[{"award-number":["25K11250"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K08376"],"award-info":[{"award-number":["20K08376"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008886","name":"Princess Takamatsu Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP26fk0210149"],"award-info":[{"award-number":["JP26fk0210149"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP26fk0210178"],"award-info":[{"award-number":["JP26fk0210178"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP26fk0210195"],"award-info":[{"award-number":["JP26fk0210195"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP266f0137007"],"award-info":[{"award-number":["JP266f0137007"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25fk0210130"],"award-info":[{"award-number":["JP25fk0210130"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005927","name":"Daiichi Sankyo Foundation of Life Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005927","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jhepr.2026.102015","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T23:18:43Z","timestamp":1788045523000},"page":"102015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["SREBP-driven lipogenesis coupled with ferroptosis resistance as a therapeutic target in PTEN-loss extrahepatic cholangiocarcinoma"],"prefix":"10.1016","volume":"8","author":[{"given":"Yuki","family":"Hayata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Tempaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6312-5706","authenticated-orcid":false,"given":"Tomoharu","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7031-5388","authenticated-orcid":false,"given":"Satoshi","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyora","family":"Izuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genki","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaro","family":"Tachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0555-2707","authenticated-orcid":false,"given":"Akiko","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4109-3421","authenticated-orcid":false,"given":"Naoto","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6796-4467","authenticated-orcid":false,"given":"Hidemasa","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6973-5094","authenticated-orcid":false,"given":"Hayato","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2026.102015_bib1","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","article-title":"Pathogenesis, diagnosis, and management of cholangiocarcinoma","volume":"145","author":"Rizvi","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2026.102015_bib2","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jhep.2006.09.001","article-title":"Cholangiocarcinoma: modern advances in understanding a deadly old disease","volume":"45","author":"Malhi","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.102015_bib3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","article-title":"Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)","volume":"13","author":"Banales","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2026.102015_bib4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41575-025-01153-w","article-title":"Cholangiocarcinoma 2026: status quo, unmet needs and priorities","volume":"23","author":"Banales","year":"2026","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2026.102015_bib5","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/ng.3375","article-title":"Genomic spectra of biliary tract cancer","volume":"47","author":"Nakamura","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhepr.2026.102015_bib6","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1158\/2159-8290.CD-17-0368","article-title":"Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma","volume":"7","author":"Jusakul","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jhepr.2026.102015_bib7","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jhep.2020.03.007","article-title":"Molecular targeted therapies: ready for \u201cprime time\u201d in biliary tract cancer","volume":"73","author":"Lamarca","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.102015_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/srep23899","article-title":"A novel mouse model of intrahepatic cholangiocarcinoma induced by liver-specific Kras activation and Pten deletion","volume":"6","author":"Ikenoue","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2026.102015_bib9","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1172\/JCI63065","article-title":"Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes","volume":"122","author":"Sekiya","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhepr.2026.102015_bib10","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1172\/JCI27282","article-title":"Induction of intrahepatic cholangiocellular carcinoma by liver-specific disruption of Smad4 and Pten in mice","volume":"116","author":"Xu","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhepr.2026.102015_bib11","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1158\/0008-5472.CAN-13-1911","article-title":"Cell lineage tracing reveals a biliary origin of intrahepatic cholangiocarcinoma","volume":"74","author":"Guest","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhepr.2026.102015_bib12","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1158\/0008-5472.CAN-11-3596","article-title":"Kras(G12D) and p53 mutation cause primary intrahepatic cholangiocarcinoma","volume":"72","author":"O\u2019Dell","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhepr.2026.102015_bib13","doi-asserted-by":"crossref","first-page":"E3806","DOI":"10.1073\/pnas.1619416114","article-title":"Biliary epithelial injury-induced regenerative response by IL-33 promotes cholangiocarcinogenesis from peribiliary glands","volume":"114","author":"Nakagawa","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhepr.2026.102015_bib14","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1158\/2159-8290.CD-15-0283","article-title":"Loss of PTEN promotes resistance to T cell-mediated immunotherapy","volume":"6","author":"Peng","year":"2016","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jhepr.2026.102015_bib15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.molmed.2019.03.003","article-title":"PTEN mutations trigger resistance to immunotherapy","volume":"25","author":"Cheng","year":"2019","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jhepr.2026.102015_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/srep12122","article-title":"Results of an abbreviated phase-II study with the Akt inhibitor MK-2206 in patients with advanced biliary cancer","volume":"5","author":"Ahn","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2026.102015_bib17","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/cncr.33364","article-title":"Phase 2 study of copanlisib in combination with gemcitabine and cisplatin in advanced biliary tract cancers","volume":"127","author":"Tan","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.jhepr.2026.102015_bib18","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/dvg.20397","article-title":"A CK19(CreERT) knockin mouse line allows for conditional DNA recombination in epithelial cells in multiple endodermal organs","volume":"46","author":"Means","year":"2008","journal-title":"Genesis"},{"key":"10.1016\/j.jhepr.2026.102015_bib19","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1101\/gad.1475506","article-title":"Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression","volume":"20","author":"Ijichi","year":"2006","journal-title":"Genes Dev"},{"key":"10.1016\/j.jhepr.2026.102015_bib20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/5007","article-title":"Generalized lacZ expression with the ROSA26 Cre reporter strain","volume":"21","author":"Soriano","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhepr.2026.102015_bib21","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S1074-7613(01)00134-0","article-title":"T cell-specific loss of Pten leads to defects in central and peripheral tolerance","volume":"14","author":"Suzuki","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.jhepr.2026.102015_bib22","doi-asserted-by":"crossref","DOI":"10.1172\/JCI151895","article-title":"Inhibiting SCAP\/SREBP exacerbates liver injury and carcinogenesis in murine nonalcoholic steatohepatitis","volume":"132","author":"Kawamura","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhepr.2026.102015_bib23","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1073\/pnas.1322731111","article-title":"Loss of liver E-cadherin induces sclerosing cholangitis and promotes carcinogenesis","volume":"111","author":"Nakagawa","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhepr.2026.102015_bib24","article-title":"Cell fate analysis of zone 3 hepatocytes in liver injury and tumorigenesis","volume":"3","author":"Kurosaki","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2026.102015_bib25","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1053\/j.gastro.2021.01.028","article-title":"Axin2+ peribiliary glands in the periampullary region generate biliary epithelial stem cells that give rise to ampullary carcinoma","volume":"160","author":"Hayata","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2026.102015_bib26","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.223123","article-title":"Chk1-mediated Cdc25A degradation as a critical mechanism for normal cell cycle progression","volume":"132","author":"Goto","year":"2019","journal-title":"J Cell Sci"},{"key":"10.1016\/j.jhepr.2026.102015_bib27","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1111\/cas.70153","article-title":"Aurora-A promotes cell-cycle progression from quiescence through primary cilia disassembly","volume":"116","author":"Kohso","year":"2025","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jhepr.2026.102015_bib28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2020.03.008","article-title":"Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma","volume":"73","author":"Montal","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.102015_bib29","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/hep.28326","article-title":"The hepatic, biliary, and pancreatic network of stem\/progenitor cell niches in humans: a new reference frame for disease and regeneration","volume":"64","author":"Lanzoni","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2026.102015_bib30","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.3390\/ijms19061745","article-title":"Peribiliary glands as the cellular origin of biliary tract cancer","volume":"19","author":"Nakagawa","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhepr.2026.102015_bib31","doi-asserted-by":"crossref","first-page":"16392","DOI":"10.1073\/pnas.1101263108","article-title":"HER2 overcomes PTEN (loss)-induced senescence to cause aggressive prostate cancer","volume":"108","author":"Ahmad","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhepr.2026.102015_bib32","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrendo.2017.91","article-title":"SREBP-regulated lipid metabolism: convergent physiology\u2013divergent pathophysiology","volume":"13","author":"Shimano","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jhepr.2026.102015_bib33","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3390\/cancers13030474","article-title":"Lipid metabolism in oncology: why it matters, how to research, and how to treat","volume":"13","author":"Matsushita","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jhepr.2026.102015_bib34","doi-asserted-by":"crossref","first-page":"5689","DOI":"10.1021\/acs.jmedchem.0c02179","article-title":"Discovery of a vitamin D receptor-silent vitamin D derivative that impairs sterol regulatory element-binding protein in vivo","volume":"64","author":"Kawagoe","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.jhepr.2026.102015_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmgh.2024.101402","article-title":"XBP1 facilitating NF-\u03baB-p65 nuclear translocation promotes macrophage-originated sterile inflammation via regulating MT2 transcription in the ischemia\/reperfusion liver","volume":"18","author":"Rao","year":"2024","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2026.102015_bib36","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1128\/MCB.00847-14","article-title":"NF-\u03baB signaling is required for XBP1 (unspliced and spliced)-mediated effects on antiestrogen responsiveness and cell fate decisions in breast cancer","volume":"35","author":"Hu","year":"2015","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jhepr.2026.102015_bib37","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ccr.2014.07.001","article-title":"ER stress cooperates with hypernutrition to trigger TNF-dependent spontaneous HCC development","volume":"26","author":"Nakagawa","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jhepr.2026.102015_bib38","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.devcel.2025.02.004","article-title":"Mechanisms of ferroptosis sensitization and resistance","volume":"60","author":"Lee","year":"2025","journal-title":"Dev Cell"},{"key":"10.1016\/j.jhepr.2026.102015_bib39","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1007\/s00204-025-04052-w","article-title":"Lipogenesis and MASLD: re-thinking the role of SREBPs","volume":"99","author":"Nakagawa","year":"2025","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.jhepr.2026.102015_bib40","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s10120-021-01159-8","article-title":"Apatinib induced ferroptosis by lipid peroxidation in gastric cancer","volume":"24","author":"Zhao","year":"2021","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.jhepr.2026.102015_bib41","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41419-023-05738-8","article-title":"Fatostatin induces ferroptosis through inhibition of the AKT\/mTORC1\/GPX4 signaling pathway in glioblastoma","volume":"14","author":"Cai","year":"2023","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jhepr.2026.102015_bib42","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/1878-0261.12078","article-title":"K-Ras mutation and amplification status is predictive of resistance and high basal pAKT is predictive of sensitivity to everolimus in biliary tract cancer cell lines","volume":"11","author":"Yeung","year":"2017","journal-title":"Mol Oncol"},{"key":"10.1016\/j.jhepr.2026.102015_bib43","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1053\/j.gastro.2015.11.039","article-title":"Epithelial transforming growth factor-\u03b2 signaling does not contribute to liver fibrosis but protects mice from cholangiocarcinoma","volume":"150","author":"Mu","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2026.102015_bib44","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jhep.2024.02.018","article-title":"PTEN deficiency induces an extrahepatic cholangitis-cholangiocarcinoma continuum via aurora kinase A in mice","volume":"81","author":"Yang","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.102015_bib45","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3390\/cancers10110447","article-title":"Lipid metabolic reprogramming in hepatocellular carcinoma","volume":"10","author":"Nakagawa","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jhepr.2026.102015_bib46","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s13046-024-03235-0","article-title":"Ferroptosis and the tumor microenvironment","volume":"43","author":"Cui","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.jhepr.2026.102015_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1119369","article-title":"Ferroptosis and tumor immunotherapy: a promising combination therapy for tumors","volume":"13","author":"Cai","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.jhepr.2026.102015_bib48","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1101\/gad.314674.118","article-title":"Regulation of lipid peroxidation and ferroptosis in diverse species","volume":"32","author":"Conrad","year":"2018","journal-title":"Genes Dev"},{"key":"10.1016\/j.jhepr.2026.102015_bib49","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12943-024-01999-9","article-title":"Ferroptotic therapy in cancer: benefits, side effects, and risks","volume":"23","author":"Diao","year":"2024","journal-title":"Mol Cancer"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555926002867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555926002867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:53:32Z","timestamp":1792000412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555926002867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2589555926002867"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2026.102015","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SREBP-driven lipogenesis coupled with ferroptosis resistance as a therapeutic target in PTEN-loss extrahepatic cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2026.102015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"102015"}}